1.
Litzow M, Lee S, Bennett J, Dewald G, Gallagher R, Jain V, Paietta E, Racevskis J, Rousey, Mazza J, Tallman M. A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia. Haematologica [Internet]. 2006Aug.1 [cited 2026Nov.13];91(8):1105-8. Available from: https://haematologica.org/article/view/4100